(PharmaNewsWire.Com, December 22, 2017 ) The Middle East and Africa Stem Cell Assay Market was worth USD 43.3 Million in 2016 and is estimated to be growing at a CAGR of 16.3%, to reach USD 92.24 Million by 2021. Stem cells acquired from human embryo have the potential to grow into any type of cell in the body as they are not differentiated. Stem cell research is very useful to get to know about development of human body from embryo. It might help to identify the role of genes in the genetic mutations or traits received by a body.
Stem cell researchers say that stem cells can eventually be used to repair damaged blood vessels thus helping patients with cardiovascular diseases. They can also be used to treat diseases related to the brain such as Alzheimers and Parkinsons disease and carefully developed heart cells in the laboratory can be used to transplanted in patients with heart diseases to develop healthy tissues.
Increase in demand for new and advanced therapies to deal with the increasing chronic diseases led to the increase in demand for stem cell therapy. As the animals are not being allowed to use for drug testing and increase in the applications of stem cells in various fields, stem cell assay market is expected to grow at a rapid pace. However, danger of killing the embryo to derive stem cells and absence of required infrastructure are inhibiting the market.
The Middle East and Africa stem cell assay market is segmented based on assay type, technology, kits, product, application, end user and region. Based on the assay type, the market is categorized into Cell Viability & Toxicity Assays, Purification Assays, Differentiation assays, function assays, Identification assays, proliferation assays and cell apoptosis assays. The cell viability and toxicity assay is projected to hold the largest market share due to increase in focus on drug testing using stem cells. Based on kits, the market is categorized into Adult stem cell kits and human embryonic stem cell kits. Adult stem cells kits are again segmented into Induced Pluripotent Stem Cell Kits, Mesenchymal Stem Cell Kits, Hematopoietic Stem Cell Kits, Umbilical Cord Stem Cells and Neuronal Stem Cells Kits. Due to the high effectiveness in the analysis of stem cells, adult stem cell kits segment is rapidly growing. Based on product, the market is categorized into Instruments and Detection kits. Instruments are further categorized into Flow cytometer, Cell imaging systems, Micro electrode arrays and automated cell counter. Detection kits include immune histochemistry kits. Flow cytometer is the fastest growing segment due to the rise in demand for tissue analysis and application of cytometers in cancer detection. Based on application, the market is categorized into Regenerative Medicine & Therapy Development, Drug Discovery and Development and clinical research. Regenerative medicine segment is again categorized into Dermatology, Cardiovascular, Orthopedic & Musculoskeletal Spine, Oncology, Central Nervous System and diabetes. Due to the increase in prevalence of chronic diseases, the demand for regenerative medicine has increased attributing to its largest market share. Based on the end users, the market is categorized into research institutes and industry research.
The stem cell assay market in this region is analyzed under Middle East and Africa. The growth rate of the market is somewhat slow because of the economic conditions of the countries. However, developing countries like South Africa are slowly adopting the stem cell therapy resulting in the growth of the market.
Some of the major companies in the stem cell assay market are Bio-Techne Corporation, Thermo Fisher Scientific Inc., Merck KGaA, STEMCELL Technologies Inc., Promega Corporation, GE Healthcare, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., Hemogenix, and Cell Biolabs Inc
Market Segmentation Assay Type
1)Introduction Cell Viability & Toxicity Assays Cell Identification Assays Cell Differentiation Assays Isolation/Purification Assays Cell Proliferation Assays Cell Apoptosis Assays Cell Function Assays Y-o-Y Growth Analysis, By Assay Type Market Attractiveness Analysis, By Assay Type Market Share Analysis, By Assay Type
2)Technology Introduction Technology Roadmap Micro Fabricated Assisted Technology Microfluidics Based Cell Trap Technologies Technology in Development Y-o-Y Growth Analysis, By Technology Market Attractiveness Analysis, By Technology Market Share Analysis, By Technology
5)Application Introduction Regenerative Medicine & Therapy Development Orthopedic & Musculoskeletal Spine Central Nervous System Dermatology Cardiovascular Diabetes Oncology Others Drug Discovery and Development Clinical Research
6)End User Introduction Research Institutes Industry Research
About us : Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.
Contact us: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
